Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester

4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester

4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester structure

4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester 

structure
  • CAS No:

    877399-50-3

  • Formula:

    C13H20BrN3O2

  • Chemical Name:

    4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester

  • Synonyms:

    4-(4-Bromo-pyrazol-1-yl)-piperidine-1-carboxylic acid tert-butyl ester;1-(4-BOC-Piperidino)-4-bromopyrazole;(R)-5-broMo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-a;1-Boc-4-(4-broMopyrazol-1-yl)piperidine;tert-butyl 4-(4-broMo-1H-pyrazol-1-yl)piperidine-1-carbo×ylate;1-Piperidinecarboxylicacid, 4-(4-broMo-1H-pyrazol-1-yl)-, 1,1-diMethylethyl ester;tert-Butyl 4-(4-bromopyrazol-1-yl)piperidine-1-carboxylate;1-Boc-4-(4-bromo-1H-pyrazol-1-yl)piperidine

  • Categories:

    Pharmaceutical Intermediates  >  Antineoplastics

4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester Basic Attributes

330.22

329.073883

DTXSID90670276

2933990090

Characteristics

47.4

2.3

Off-white Solid

1.4±0.1 g/cm3

77.0 to 81.0 °C

411.5°C at 760 mmHg

202.7±25.9 °C

1.594

Room temperature.

Safety Information

22

Xn

P264, P270, P301+P312, P330, P501

H302

|Warning|H302 (97.44%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory.

4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester Use and Manufacturing

2.08 kg of cesium carbonate, 0.78 kg of 4-bromopyrazole was dissolved in 4 liters of N-methylpyrrolidone, Heated to 80 degrees, A 5 liter solution of N-methylpyrrolidone was added to 1.8 kg of compound (CZT-7)Reaction for 12 hours.Cooled to room temperature, Add 50 litersMethyl tert-butyl etherwith50 liters of water, Stir for 1 hour.After dispensing, The organic phase was washed with 20 liters of * 4 water and dried 50percentLiter of hexane and stirred at room temperature for 2 hours. Filtered and dried to give 1.35 kg of compound (CZT-8) in a yield of 77percentB. To a cold solution (0 °C) of 4-bromo-lH-pyrazole (14.9 g, 0.10 mol) in 80 mL of dichloromethane was added sodium hydride (8.13 g, 0.20 mol) portion wise. The mixture was stirred at 0 °C for 1 hour, followed by the addition of a solution of tert-butyl 4-((methylsulfonyl)oxy)piperidine-l-carboxylate (34.0 g, 0.12 mol) in 30 mL of N, N-dimethylformamide. The resulting mixture was heated at 110 °C overnight. Purification by column chromatography afforded tert-butyl 4-(4-bromo-lH- pyrazol-l-yl)piperidine-l-carboxylate as a yellow oil in 58percent yield (19.5 g). To a stirred solution of 4-bromo-pyrazole (10.44 g, 71.03 mmol) in anhydrous DMF (96 mL), cooled to 0° C., was slowly added NaH (60percent in mineral oil) (3.13 g, 78.133 mmol). To a stirred solution of 4-bromo-pyrazole (10.44 g, 71.03 mmol) in anhydrous DMF (96 mL), cooled to 0°C, was slowly added NaH (60percent in mineral oil) (3.13 g, 78.133 mmol). The solution was stirred for 1 hour at 0°C. 4-Methanesulfonyloxy-piperidine-1-carboxylic acid tert-butyl ester (19.82 g , 71.03 mmol) was added slowly and the reaction was heated to 100°C overnight or until consumption of the pyrazole by NMR. The reaction was cooled to room temperature and water added (20 mL) followed by extraction with EtOAc. The combined extracts were washed with saturated aqueous NaCI (4 x 20 mL), dried with NaA mixture of 3-(4-ethylpyridin-3-yl)-N1, N1-bis-(4-methoxybenzyl)-[2, 7]naphthyridine-1, 6-diamine (150 mg, 0.29 mmol), To

Computed Properties

Molecular Weight:330.22
XLogP3:2.3
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:329.07389
Monoisotopic Mass:329.07389
Topological Polar Surface Area:47.4
Heavy Atom Count:19
Complexity:324
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.